Bristol Myers Squibb Stock In The News
BMY Stock | USD 48.86 0.13 0.27% |
The overall news coverage of Bristol Myers Squibb from major news outlets shows bullish sentiment on 53 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of Bristol Myers' news coverage and content from conventional and social sources shows investors' bearish mood towards Bristol Myers Squibb. The specific impact of Bristol Myers news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Bristol Myers' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Bristol Myers headlines in addition to utilizing other, more conventional financial analysis modules. Check out Bristol Myers Backtesting and Bristol Myers Hype Analysis.
Bristol |
Bristol Myers Today Top News and Investor Outlook
Bristol Myers Squibb Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Bristol and other traded companies coverage. We help investors stay connected with Bristol headlines for the 25th of April to make an informed investment decision based on correlating the impacts of news items on Bristol Stock performance. Please note that trading solely based on the Bristol Myers Squibb hype is not for everyone as timely availability and quick action are needed to avoid losses.Bristol Myers stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Bristol earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Bristol Myers that are available to investors today. That information is available publicly through Bristol media outlets and privately through word of mouth or via Bristol internal channels. However, regardless of the origin, that massive amount of Bristol data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bristol Myers news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bristol Myers relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bristol Myers' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bristol Myers alpha.
Bristol Largest EPS Surprises
Earnings surprises can significantly impact Bristol Myers' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2006-10-26 | 2006-09-30 | 0.2 | 0.22 | 0.02 | 10 | ||
2007-01-25 | 2006-12-31 | 0.16 | 0.19 | 0.03 | 18 | ||
2006-01-25 | 2005-12-31 | 0.28 | 0.31 | 0.03 | 10 | ||
2002-07-23 | 2002-06-30 | 0.26 | 0.23 | -0.03 | 11 | ||
2015-10-27 | 2015-09-30 | 0.35 | 0.39 | 0.04 | 11 | ||
2003-03-10 | 2002-12-31 | 0.27 | 0.31 | 0.04 | 14 |
Bristol Myers Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Bristol Myers Squibb Stock. The global stock market is bearish. About 60% of major world exchanges and indexes are down. See today's market update for more information.24th of April 2024
HDAC Inhibitor Market to Observe Stunning Growth During the Study Period DelveInsight at finance.yahoo.com
22nd of April 2024
Bristol Myers, Cellares ink 380M CAR-T therapies supply deal at seekingalpha.com
19th of April 2024
Got 500 3 Healthcare Stocks to Buy and Hold Forever at fool.com
18th of April 2024
UK-based Pathios Therapeutics raises 23.4 million Series B to advance first-in-class immun... at eu-startups.com
17th of April 2024
Disposition of 842 shares by Samit Hirawat of Bristol Myers subject to Rule 16b-3 at finance.yahoo.com
16th of April 2024
Asher Bio Closes 55 Million Series C Financing to Advance Lead Program into Phase 1b Clini... at businesswire.com
11th of April 2024
A Closer Look At Bristol-Myers Squibb Companys Impressive ROE at finance.yahoo.com
8th of April 2024
SHAREHOLDER ALERT Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol... at benzinga.com
3rd of April 2024
Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for ... at globenewswire.com
Bristol Myers Investors Sentiment
The influence of Bristol Myers' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Bristol. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Bristol Myers' public news can be used to forecast risks associated with an investment in Bristol. The trend in average sentiment can be used to explain how an investor holding Bristol can time the market purely based on public headlines and social activities around Bristol Myers Squibb. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Bristol Myers' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bristol Myers' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Bristol Myers' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Bristol Myers.
Bristol Myers Implied Volatility | 84.57 |
Bristol Myers' implied volatility exposes the market's sentiment of Bristol Myers Squibb stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bristol Myers' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bristol Myers stock will not fluctuate a lot when Bristol Myers' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bristol Myers in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bristol Myers' short interest history, or implied volatility extrapolated from Bristol Myers options trading.
Check out Bristol Myers Backtesting and Bristol Myers Hype Analysis. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Bristol Stock analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Bristol Myers' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myers. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myers listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.09) | Dividend Share 2.31 | Earnings Share 3.86 | Revenue Per Share 21.753 | Quarterly Revenue Growth 0.006 |
The market value of Bristol Myers Squibb is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myers' value that differs from its market value or its book value, called intrinsic value, which is Bristol Myers' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myers' market value can be influenced by many factors that don't directly affect Bristol Myers' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myers' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bristol Myers is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myers' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.